Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1Low-Grade Intraepithelial Neoplasia of Cervix 1Esophageal Neoplasms 1Deglutition Disorders 1

Interventions

Cisplatin 2tislelizumab 1pembrolizumab 1epigallocatechin gallate 1durvalumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Nivolumab 1Niacinamide 1Immunotherapy 1Hyaluronic Acid 1Esophagectomy 1Drug Therapy 1Cryotherapy 1Cetuximab 1Carboplatin 1Brachytherapy 1Aerosols 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Deglutition Disorders × epigallocatechin gallate × Clear all
NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Shandong Cancer Hospital and Institute

Phase 2 Unknown
72 enrolled
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡